Report cover image

Interventional Oncology Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Oct 29, 2024
Length 137 Pages
SKU # PROD19315176

Description

Interventional Oncology Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global interventional oncology market is expected to grow at a CAGR of around 6.5% during 2025-2034. This report on global interventional oncology market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global interventional oncology market by segmenting the market based on product, procedure, cancer type, end user, and region. Also, detailed profiles of companies operating in the interventional oncology market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Growing Demand for Minimally Invasive Therapeutics
• Rising Patient Preference for Minimally Invasive Procedures

Market Challenges

• Dearth of Well-Trained Specialists
• Limited Clinical Data to Support Therapeutic Efficacy

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product

• Embolization Devices
• Radioembolic Agents
• Non-Radio Embolic Agents
Microspheres
Coated Beads
Microparticles
• Ablation Devices
Radiofrequency (RF) Ablation Devices
Microwave Ablation Devices
Cryoablation Devices
Other Ablation Devices
• Support Devices
Microcatheters
Guidewires

Market by Procedure

• Tumor Embolization
Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
Transcatheter Arterial Chemoembolization (TACE)
Transcatheter Arterial embolization/Bland Embolization
• Tumor ablation
• Thermal Ablation
Microwave Ablation
Radiofrequency Ablation
Cryoablation
Others
• Non-thermal Ablation
Irreversible Electroporation

Market by Cancer Type

• Liver Cancer
• Lung Cancer
• Bone Metastasis
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Other Cancers

Market by End User

• Hospitals
• Ambulatory Surgery Centers
• Research & Academic Institutes

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
Rest of Middle East & Africa

Table of Contents

137 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Interventional Oncology Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Interventional Oncology Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Interventional Oncology Market by Product
5.1. Introduction
5.2. Embolization Devices
5.3. Radioembolic Agents
5.4. Non-Radio embolic Agents
5.4.1. Microspheres
5.4.2.Coated Beads
5.4.3.Microparticles
5.5. Ablation Devices
5.5.1. Radiofrequency (RF) Ablation Devices
5.5.2.Microwave Ablation Devices
5.5.3.Cryoablation Devices
5.5.4.Other Ablation Devices
5.6. Support Devices
5.6.1. Microcatheters
5.6.2.Guidewires
6. Global Interventional Oncology Market by Procedure
6.1. Introduction
6.2. Tumor Embolization
6.2.1. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
6.2.2.Transcatheter Arterial Chemoembolization (TACE)
6.2.3.Transcatheter Arterial embolization/Bland Embolization
6.3. Tumor ablation
6.4. Thermal Ablation
6.4.1. Microwave Ablation
6.4.2. Radiofrequency Ablation
6.4.3. Cryoablation
6.4.4. Others
6.5. Non-thermal Ablation
6.5.1. Irreversible Electroporation
7. Global Interventional Oncology Market by Cancer Type
7.1. Introduction
7.2. Liver Cancer
7.3. Lung Cancer
7.4. Bone Metastasis
7.5. Kidney Cancer
7.6. Breast Cancer
7.7. Prostate Cancer
7.8. Other Cancers
8. Global Interventional Oncology Market by End User
8.1. Introduction
8.2. Hospitals
8.3. Ambulatory Surgery Centers
8.4. Research & Academic Institutes
9. Global Interventional Oncology Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. AngioDynamics
13.2.2. BD
13.2.3. Boston Scientific
13.2.4. Cook Medical
13.2.5. HealthTronics
13.2.6. J&J
13.2.7. Medtronic
13.2.8. Merit Medical
13.2.9. Teleflex
13.2.10. Terumo
List of Figures
Figure 1: Global Interventional Oncology Market (in US$ Million), 2020-2024
Figure 2: Global Interventional Oncology Market by Product, 2024
Figure 3: Global Interventional Oncology Market by Procedure, 2024
Figure 4: Global Interventional Oncology Market by Cancer Type, 2024
Figure 5: Global Interventional Oncology Market by End User, 2024
Figure 6: Global Interventional Oncology Market by Region, 2024
Figure 7: Global Interventional Oncology Market (in US$ Million), 2025-2034
Figure 8: Global Interventional Oncology Market by Product (in %), 2024 & 2034
Figure 9: Global Embolization Devices Interventional Oncology Market (in US$ Million), 2020-2024
Figure 10: Global Embolization Devices Interventional Oncology Market (in US$ Million), 2025-2034
Figure 11: Global Radioembolic Agents Interventional Oncology Market (in US$ Million), 2020-2024
Figure 12: Global Radioembolic Agents Interventional Oncology Market (in US$ Million), 2025-2034
Figure 13: Global Non-Radio Embolic Agents Interventional Oncology Market (in US$ Million), 2020-2024
Figure 14: Global Non-Radio embolic Agents Interventional Oncology Market (in US$ Million), 2025-2034
Figure 15: Microspheres Non-Radio embolic Agents Interventional Oncology Market (in US$ Million), 2020-2034
Figure 16: Coated Beads Non-Radio embolic Agents Interventional Oncology Market (in US$ Million), 2020-2034
Figure 17: Microparticles Non-Radio embolic Agents Interventional Oncology Market (in US$ Million), 2020-2034
Figure 18: Global Ablation Devices Interventional Oncology Market (in US$ Million), 2020-2024
Figure 19: Global Ablation Devices Interventional Oncology Market (in US$ Million), 2025-2034
Figure 20: Radiofrequency (RF) Ablation Devices Interventional Oncology Market (in US$ Million), 2020-2034
Figure 21: Microwave Ablation Devices Interventional Oncology Market (in US$ Million), 2020-2034
Figure 22: Cryoablation Ablation Devices Interventional Oncology Market (in US$ Million), 2020-2034
Figure 23: Other Ablation Devices Interventional Oncology Market (in US$ Million), 2020-2034
Figure 24: Global Support Devices Interventional Oncology Market (in US$ Million), 2020-2024
Figure 25: Global Support Devices Interventional Oncology Market (in US$ Million), 2025-2034
Figure 26: Microcatheters Support Devices Interventional Oncology Market (in US$ Million), 2020-2034
Figure 27: Guidewires Support Devices Interventional Oncology Market (in US$ Million), 2020-2034
Figure 28: Global Interventional Oncology Market by Procedure (in %), 2024 & 2034
Figure 29: Global Tumor Embolization Interventional Oncology Market (in US$ Million), 2020-2024
Figure 30: Global Tumor Embolization Interventional Oncology Market (in US$ Million), 2025-2034
Figure 31: Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy Interventional Oncology Market (in US$ Million), 2020-2034
Figure 32: Transcatheter Arterial Chemoembolization (TACE) Interventional Oncology Market (in US$ Million), 2020-2034
Figure 33: Transcatheter Arterial embolization/Bland Embolization Interventional Oncology Market (in US$ Million), 2020-2034
Figure 34: Global Tumor ablation Interventional Oncology Market (in US$ Million), 2020-2024
Figure 35: Global Tumor ablation Interventional Oncology Market (in US$ Million), 2025-2034
Figure 36: Global Thermal Ablation Interventional Oncology Market (in US$ Million), 2020-2024
Figure 37: Global Thermal Ablation Interventional Oncology Market (in US$ Million), 2025-2034
Figure 38: Microwave Ablation Interventional Oncology Market (in US$ Million), 2020-2034
Figure 39: Radiofrequency Ablation Interventional Oncology Market (in US$ Million), 2020-2034
Figure 40: Cryoablation Interventional Oncology Market (in US$ Million), 2020-2034
Figure 41: Other Procedures Interventional Oncology Market (in US$ Million), 2020-2034
Figure 42: Global Non-thermal Ablation Interventional Oncology Market (in US$ Million), 2020-2024
Figure 43: Global Non-thermal Ablation Interventional Oncology Market (in US$ Million), 2025-2034
Figure 44: Irreversible Electroporation Interventional Oncology Market (in US$ Million), 2020-2034
Figure 45: Global Interventional Oncology Market by Cancer Type (in %), 2024 & 2034
Figure 46: Global Liver Cancer Interventional Oncology Market (in US$ Million), 2020-2024
Figure 47: Global Liver Cancer Interventional Oncology Market (in US$ Million), 2025-2034
Figure 48: Global Lung Cancer Interventional Oncology Market (in US$ Million), 2020-2024
Figure 49: Global Lung Cancer Interventional Oncology Market (in US$ Million), 2025-2034
Figure 50: Global Bone Metastasis Interventional Oncology Market (in US$ Million), 2020-2024
Figure 51: Global Bone Metastasis Interventional Oncology Market (in US$ Million), 2025-2034
Figure 52: Global Kidney Cancer Interventional Oncology Market (in US$ Million), 2020-2024
Figure 53: Global Kidney Cancer Interventional Oncology Market (in US$ Million), 2025-2034
Figure 54: Global Breast Cancer Interventional Oncology Market (in US$ Million), 2020-2024
Figure 55: Global Breast Cancer Interventional Oncology Market (in US$ Million), 2025-2034
Figure 56: Global Prostate Cancer Interventional Oncology Market (in US$ Million), 2020-2024
Figure 57: Global Prostate Cancer Interventional Oncology Market (in US$ Million), 2025-2034
Figure 58: Global Other Cancers Interventional Oncology Market (in US$ Million), 2020-2024
Figure 59: Global Other Cancers Interventional Oncology Market (in US$ Million), 2025-2034
Figure 60: Global Interventional Oncology Market by End User (in %), 2024 & 2034
Figure 61: Global Hospitals Interventional Oncology Market (in US$ Million), 2020-2024
Figure 62: Global Hospitals Interventional Oncology Market (in US$ Million), 2025-2034
Figure 63: Global Ambulatory Surgery Centers Interventional Oncology Market (in US$ Million), 2020-2024
Figure 64: Global Ambulatory Surgery Centers Interventional Oncology Market (in US$ Million), 2025-2034
Figure 65: Global Research & Academic Institutes Interventional Oncology Market (in US$ Million), 2020-2024
Figure 66: Global Research & Academic Institutes Interventional Oncology Market (in US$ Million), 2025-2034
Figure 67: Global Interventional Oncology Market by Region (in %), 2024 & 2034
Figure 68: Europe Interventional Oncology Market (in US$ Million), 2020-2024
Figure 69: Europe Interventional Oncology Market (in US$ Million), 2025-2034
Figure 70: Europe Interventional Oncology Market by Country (in %), 2024 & 2034
Figure 71: Germany Interventional Oncology Market (in US$ Million), 2020-2034
Figure 72: United Kingdom Interventional Oncology Market (in US$ Million), 2020-2034
Figure 73: France Interventional Oncology Market (in US$ Million), 2020-2034
Figure 74: Italy Interventional Oncology Market (in US$ Million), 2020-2034
Figure 75: Spain Interventional Oncology Market (in US$ Million), 2020-2034
Figure 76: Russia Interventional Oncology Market (in US$ Million), 2020-2034
Figure 77: Netherlands Interventional Oncology Market (in US$ Million), 2020-2034
Figure 78: North America Interventional Oncology Market (in US$ Million), 2020-2024
Figure 79: North America Interventional Oncology Market (in US$ Million), 2025-2034
Figure 80: North America Interventional Oncology Market by Country (in %), 2024 & 2034
Figure 81: United States Interventional Oncology Market (in US$ Million), 2020-2034
Figure 82: Canada Interventional Oncology Market (in US$ Million), 2020-2034
Figure 83: Asia Pacific Interventional Oncology Market (in US$ Million), 2020-2024
Figure 84: Asia Pacific Interventional Oncology Market (in US$ Million), 2025-2034
Figure 85: Asia Pacific Interventional Oncology Market by Country (in %), 2024 & 2034
Figure 86: China Interventional Oncology Market (in US$ Million), 2020-2034
Figure 87: Japan Interventional Oncology Market (in US$ Million), 2020-2034
Figure 88: India Interventional Oncology Market (in US$ Million), 2020-2034
Figure 89: South Korea Interventional Oncology Market (in US$ Million), 2020-2034
Figure 90: Australia Interventional Oncology Market (in US$ Million), 2020-2034
Figure 91: Indonesia Interventional Oncology Market (in US$ Million), 2020-2034
Figure 92: Latin America Interventional Oncology Market (in US$ Million), 2020-2024
Figure 93: Latin America Interventional Oncology Market (in US$ Million), 2025-2034
Figure 94: Latin America Interventional Oncology Market by Country (in %), 2024 & 2034
Figure 95: Mexico Interventional Oncology Market (in US$ Million), 2020-2034
Figure 96: Brazil Interventional Oncology Market (in US$ Million), 2020-2034
Figure 97: Argentina Interventional Oncology Market (in US$ Million), 2020-2034
Figure 98: Middle East & Africa Interventional Oncology Market (in US$ Million), 2020-2024
Figure 99: Middle East & Africa Interventional Oncology Market (in US$ Million), 2025-2034
Figure 100: Middle East & Africa Interventional Oncology Market by Country (in %), 2024 & 2034
Figure 101: Saudi Arabia Interventional Oncology Market (in US$ Million), 2020-2034
Figure 102: Turkey Interventional Oncology Market (in US$ Million), 2020-2034
Figure 103: Iran Interventional Oncology Market (in US$ Million), 2020-2034
Figure 104: UAE Interventional Oncology Market (in US$ Million), 2020-2034
Figure 105: Market Value Chain
List of Tables
Table 1: Global Interventional Oncology Market Portraiture
Table 2: Global Interventional Oncology Market by Product (in US$ Million), 2024 & 2034
Table 3: Non-Radio Embolic Agents Interventional Oncology Market by Product (in US$ Million), 2024 & 2034
Table 4: Ablation Devices Interventional Oncology Market by Product (in US$ Million), 2024 & 2034
Table 5: Support Devices Interventional Oncology Market by Product (in US$ Million), 2024 & 2034
Table 6: Global Interventional Oncology Market by Procedure (in US$ Million), 2024 & 2034
Table 7: Tumor Embolization Interventional Oncology Market by Procedure (in US$ Million), 2024 & 2034
Table 8: Thermal Ablation Interventional Oncology Market by Procedure (in US$ Million), 2024 & 2034
Table 9: Non-thermal Ablation Interventional Oncology Market by Procedure (in US$ Million), 2024 & 2034
Table 10: Global Interventional Oncology Market by Cancer Type (in US$ Million), 2024 & 2034
Table 11: Global Interventional Oncology Market by End User (in US$ Million), 2024 & 2034
Table 12: Global Interventional Oncology Market by Region (in US$ Million), 2024 & 2034
Table 13: Europe Interventional Oncology Market by Country (in US$ Million), 2024 & 2034
Table 14: North America Interventional Oncology Market by Country (in US$ Million), 2024 & 2034
Table 15: Asia Pacific Interventional Oncology Market by Country (in US$ Million), 2024 & 2034
Table 16: Latin America Interventional Oncology Market by Country (in US$ Million), 2024 & 2034
Table 17: Middle East & Africa Interventional Oncology Market by Country (in US$ Million), 2024 & 2034
Table 18: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us